Akinari Mizokami

705 citations

35 papers · 355 indexed · h-index 11

Co-authors: Atsushi Kawakami Hideki Nakamura Tomoki Origuchi Mami Tamai Shin‐ya Kawashiri Satoshi Yamasaki Katsumi Eguchi Keita Fujikawa
Topics: Rheumatoid Arthritis Research and Therapies (14 papers)Systemic Lupus Erythematosus Research (7 papers)Chronic Lymphocytic Leukemia Research (6 papers)
Cited by: Rheumatology Hematology Immunology
Journals: PLoS ONE Frontiers in Immunology Annals of the Rheumatic Diseases
Partner nations: Japan

In The Last Decade

Akinari Mizokami

33 papers receiving 348 citations

Peers

Countries citing papers authored by Akinari Mizokami

Since Specialization

Citations

This map shows the geographic impact of Akinari Mizokami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akinari Mizokami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akinari Mizokami more than expected).

Fields of papers citing papers by Akinari Mizokami

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akinari Mizokami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akinari Mizokami. The network helps show where Akinari Mizokami may publish in the future.

Co-authorship network of co-authors of Akinari Mizokami

This figure shows the co-authorship network connecting the top 25 collaborators of Akinari Mizokami. A scholar is included among the top collaborators of Akinari Mizokami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akinari Mizokami. Akinari Mizokami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical Characteristics of Patients With IgG4-Related Disease Complicated by Hypocomplementemia 2022 ·Frontiers in Immunology ·Yuya Fujita,Shoichi Fukui,Masataka Umeda,(unknown),Naoki Iwamoto,Yoshikazu Nakashima,Yoshiro Horai,Takahisa Suzuki,Akitomo Okada,Toshiyuki Aramaki,Yukitaka Ueki,Akinari Mizokami,Tomoki Origuchi,Hiroshi Watanabe,Kiyoshi Migita,Atsushi Kawakami	7
2	Systemic Lupus Erythematosus Complicated with Listeria Monocytogenes Infection in a Pregnant Woman 2020 ·Internal Medicine ·(unknown),Keita Fujikawa,Shotaro Ide,(unknown),Emiko Fujiwara,Akinari Mizokami,Atsushi Kawakami	2
3	Combination of ultrasound power Doppler‐verified synovitis and seropositivity accurately identifies patients with early‐stage rheumatoid arthritis 2019 ·International Journal of Rheumatic Diseases ·Shin‐ya Kawashiri,Keita Fujikawa,Ayako Nishino,Ayuko Takatani,Toshimasa Shimizu,Masataka Umeda,Shoichi Fukui,(unknown),Tomohiro Koga,Naoki Iwamoto,Kunihiro Ichinose,Mami Tamai,Hideki Nakamura,Tomoki Origuchi,Akinari Mizokami,Takahiro Maeda,Atsushi Kawakami	5
4	Diagnostic efficacy of ultrasound detection of enthesitis in peripheral spondyloarthritis 2019 ·Modern Rheumatology ·Keita Fujikawa,Shin‐ya Kawashiri,Yushiro Endo,Akinari Mizokami,Toshiaki Tsukada,(unknown),Masataka Uetani,Atsushi Kawakami	6
5	34 Evaluation of adverse events and relapse risk of systemic lupus erythematosus during treatment with hydroxychloroquine 2019 ·Abstracts ·Kunihiro Ichinose,Keita Fujikawa,Akinari Mizokami,Toshiyuki Aramaki,Yukitaka Ueki,Momoko Okamoto,Toshimasa Shimizu,Tomohiro Koga,Shin‐ya Kawashiri,Naoki Iwamoto,Takashi Igawa,Mami Tamai,Hideki Nakamura,Tomoki Origuchi,Atsushi Kawakami	1
6	Gastric mucormycosis complicated by a gastropleural fistula 2019 ·Medicine ·(unknown),Momoko Okamoto,Keita Fujikawa,Daisuke Yoshikawa,Akinari Mizokami,Tomo Mihara,(unknown),Kazuo Ohba,(unknown),Masahiro Nakashima,Ichiro Sekine,Shigeki Nakamura,Yoshitsugu Miyazaki,Atsushi Kawakami	18
7	Limited cutaneous systemic sclerosis with gangrene: an autopsy case 2019 ·Modern Rheumatology Case Reports ·(unknown),Keita Fujikawa,(unknown),(unknown),Kentaro Furukawa,(unknown),(unknown),Masahiro Nakashima,Akinari Mizokami	0
8	Comparative risk of hospitalized infection between biological agents in rheumatoid arthritis patients: A multicenter retrospective cohort study in Japan 2017 ·PLoS ONE ·Shunsuke Mori,Tamami Yoshitama,Toshihiko Hidaka,Fumikazu Sakai,Mizue Hasegawa,(unknown),Eiichi Suematsu,Hiroshi Tatsukawa,Akinari Mizokami,Shigeru Yoshizawa,(unknown),Yukitaka Ueki	32
9	Ultrasound-detected bone erosion is a relapse risk factor after discontinuation of biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis whose ultrasound power Doppler synovitis activity and clinical disease activity are well controlled 2017 ·Arthritis Research & Therapy ·Shin‐ya Kawashiri,Keita Fujikawa,Ayako Nishino,Akitomo Okada,Toshiyuki Aramaki,Toshimasa Shimizu,Masataka Umeda,Shoichi Fukui,Takahisa Suzuki,Tomohiro Koga,Naoki Iwamoto,Kunihiro Ichinose,Mami Tamai,Akinari Mizokami,Hideki Nakamura,Tomoki Origuchi,Yukitaka Ueki,Kiyoshi Aoyagi,Takahiro Maeda,Atsushi Kawakami	23
10	Musculoskeletal ultrasonography assists the diagnostic performance of the 2010 classification criteria for rheumatoid arthritis 2012 ·Modern Rheumatology ·Shin‐ya Kawashiri,Takahisa Suzuki,Akitomo Okada,Satoshi Yamasaki,Mami Tamai,Hideki Nakamura,Tomoki Origuchi,Akinari Mizokami,Masataka Uetani,Kiyoshi Aoyagi,Katsumi Eguchi,Atsushi Kawakami	44
11	A 44-Year-Old Japanese Female with Recurrent Pleuritis 2012 ·Respiration ·Takahiro Takazono,Sumako Yoshioka,(unknown),Akinari Mizokami,Kiyoshi Migita,Naofumi Suyama,Shigeru Kohno	0
12	Successful treatment of a patient with IgG4-related disease with a paravertebral mass lesion 2011 ·Modern Rheumatology ·Hideki Nakamura,(unknown),Tomohiro Koga,Akinari Mizokami,Satoshi Yamasaki,Mami Tamai,Tomoki Origuchi,Junji Irie,Atsushi Kawakami	7
13	Disease activity score 28 may overestimate the remission induction of rheumatoid arthritis patients treated with tocilizumab: comparison with the remission by the clinical disease activity index 2011 ·Modern Rheumatology ·Shin‐ya Kawashiri,Atsushi Kawakami,Naoki Iwamoto,Keita Fujikawa,Toshiyuki Aramaki,Mami Tamai,Satoshi Yamasaki,Hideki Nakamura,Yukitaka Ueki,Kiyoshi Migita,Akinari Mizokami,Tomoki Origuchi,Kiyoshi Aoyagi,Katsumi Eguchi	19
14	Successful treatment of a patient with IgG4-related disease with a paravertebral mass lesion 2011 ·Modern Rheumatology ·Hideki Nakamura,(unknown),Tomohiro Koga,Akinari Mizokami,Satoshi Yamasaki,Mami Tamai,Tomoki Origuchi,Junji Irie,Atsushi Kawakami	5
15	Reduction in serum levels of substance P in patients with rheumatoid arthritis by etanercept, a tumor necrosis factor inhibitor 2011 ·Modern Rheumatology ·Tomoki Origuchi,Naoki Iwamoto,Shin‐ya Kawashiri,Keita Fujikawa,Toshiyuki Aramaki,Mami Tamai,Kazuhiko Arima,Hideki Nakamura,Satoshi Yamasaki,Hiroaki Ida,Atsushi Kawakami,Yukitaka Ueki,Naoki Matsuoka,Munetoshi Nakashima,Akinari Mizokami,Yojiro Kawabe,(unknown),Takaaki Fukuda,Katsumi Eguchi	11
16	In rheumatoid arthritis patients treated with tocilizumab, the rate of clinical disease activity index (CDAI) remission at 24 weeks is superior in those with higher titers of IgM-rheumatoid factor at baseline 2011 ·Modern Rheumatology ·Shin‐ya Kawashiri,Atsushi Kawakami,Naoki Iwamoto,Keita Fujikawa,Toshiyuki Aramaki,Mami Tamai,Satoshi Yamasaki,Hideki Nakamura,Tomoki Origuchi,Yukitaka Ueki,Kiyoshi Migita,Akinari Mizokami,Kiyoshi Aoyagi,Katsumi Eguchi	14
17	Reduction in serum levels of substance P in patients with rheumatoid arthritis by etanercept, a tumor necrosis factor inhibitor 2010 ·Modern Rheumatology ·Tomoki Origuchi,Naoki Iwamoto,Shin‐ya Kawashiri,Keita Fujikawa,Toshiyuki Aramaki,Mami Tamai,Kazuhiko Arima,Hideki Nakamura,Satoshi Yamasaki,Hiroaki Ida,Atsushi Kawakami,Yukitaka Ueki,Naoki Matsuoka,Munetoshi Nakashima,Akinari Mizokami,Yojiro Kawabe,(unknown),Takaaki Fukuda,Katsumi Eguchi	15
18	A case of primary Sjögren’s syndrome complicated with inflammatory myopathy and interstitial lung disease 2010 ·Rheumatology International ·Tomohiro Koga,(unknown),Hideki Nakamura,Akinari Mizokami,Masakatsu Motomura,Atsushi Kawakami,Katsumi Eguchi	3
19	Prediction of DAS28-CRP remission in patients with rheumatoid arthritis treated with tacrolimus at 6 months by baseline variables 2009 ·Modern Rheumatology ·Toshiyuki Aramaki,Atsushi Kawakami,Naoki Iwamoto,Keita Fujikawa,Shin‐ya Kawashiri,Mami Tamai,Kazuhiko Arima,Makoto Kamachi,Satoshi Yamasaki,Hideki Nakamura,Munetoshi Nakashima,Akinari Mizokami,(unknown),Naoki Matsuoka,Yukitaka Ueki,Hiroaki Ida,Tomoki Origuchi,Kiyoshi Aoyagi,Katsumi Eguchi	8
20	A male case of primary Sjoegren's syndrome with interstitial pneumonitis and interstitial tubulo-nephritis in the absence of dry eye and dry mouth: parotid gland MRI is a useful diagnostic method for Sjoegren's syndrome. 1995 ·Japanese Journal of Clinical Immunology ·Noboru Takamura,Katsumi Eguchi,Kiyoshi Migita,T Tsukada,Akinari Mizokami,Tomoki Origuchi,Shigenobu Nagataki,Masahiro Izumi,Takashi Nakamura	1

About Akinari Mizokami

Akinari Mizokami is a scholar working on Rheumatology, Genetics and Hematology, having authored 35 papers that have together received 355 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (14 papers), Systemic Lupus Erythematosus Research (7 papers) and Chronic Lymphocytic Leukemia Research (6 papers). The work is most often cited by research in Rheumatology (242 citations), Hematology (69 citations) and Immunology (69 citations). Akinari Mizokami has collaborated with scholars based in Japan. Frequent co-authors include Atsushi Kawakami, Hideki Nakamura, Tomoki Origuchi, Mami Tamai, Shin‐ya Kawashiri, Satoshi Yamasaki, Katsumi Eguchi, Keita Fujikawa, Kiyoshi Aoyagi and Yukitaka Ueki. Their work appears in journals such as PLoS ONE, Frontiers in Immunology and Annals of the Rheumatic Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact